Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5194019
Max Phase: Preclinical
Molecular Formula: C35H56N12O10S2
Molecular Weight: 869.04
Associated Items:
ID: ALA5194019
Max Phase: Preclinical
Molecular Formula: C35H56N12O10S2
Molecular Weight: 869.04
Associated Items:
Canonical SMILES: CC(C)[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)CN)CSCc2cccc(n2)CSC[C@@H](C(=O)O)NC1=O
Standard InChI: InChI=1S/C35H56N12O10S2/c1-17(2)27-32(54)45-24(34(56)57)16-59-14-20-7-4-6-19(41-20)13-58-15-23(42-26(50)12-36)31(53)47-28(18(3)48)33(55)44-21(8-5-11-40-35(38)39)29(51)43-22(30(52)46-27)9-10-25(37)49/h4,6-7,17-18,21-24,27-28,48H,5,8-16,36H2,1-3H3,(H2,37,49)(H,42,50)(H,43,51)(H,44,55)(H,45,54)(H,46,52)(H,47,53)(H,56,57)(H4,38,39,40)/t18-,21+,22+,23+,24+,27+,28+/m1/s1
Standard InChI Key: FMAIHBFXTGTIIF-LCTUNNTLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 869.04 | Molecular Weight (Monoisotopic): 868.3684 | AlogP: -3.92 | #Rotatable Bonds: 12 |
Polar Surface Area: 376.03 | Molecular Species: ZWITTERION | HBA: 14 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.64 | CX Basic pKa: 11.49 | CX LogP: -7.17 | CX LogD: -7.73 |
Aromatic Rings: 1 | Heavy Atoms: 59 | QED Weighted: 0.05 | Np Likeness Score: 0.68 |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):